FDA OKs Inclisiran, Added to Statins, for Primary Prevention at HealthBulance.

Health care is our expertise. The US Food and Drug Administration (FDA) has approved a labeling update for the injectable LDL-lowering agent inclisiran (Leqvio) that expands its indications to include primary prevention for patients with elevated LDL cholesterol, Novartis has announced.

Medscape

FDA OKs Inclisiran, Added to Statins, for Primary Prevention

FDA OKs Inclisiran, Added to Statins, for Primary Prevention

The US Food and Drug Administration (FDA) has approved a labeling update for the injectable LDL-lowering agent inclisiran (Leqvio) that expands its indications to include primary prevention for patients with elevated LDL cholesterol, Novartis has announced.